Your browser doesn't support javascript.
loading
Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature.
Kavanagh, David; McGlasson, Sarah; Jury, Alexa; Williams, Jac; Scolding, Neil; Bellamy, Chris; Gunther, Claudia; Ritchie, Diane; Gale, Daniel P; Kanwar, Yashpal S; Challis, Rachel; Buist, Holly; Overell, James; Weller, Belinda; Flossmann, Oliver; Blunden, Mark; Meyer, Eric P; Krucker, Thomas; Evans, Stephen J W; Campbell, Iain L; Jackson, Andrew P; Chandran, Siddharthan; Hunt, David P J.
Afiliación
  • Kavanagh D; National Renal Complement Therapeutics Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • McGlasson S; Medical Research Council Institute of Genetics and Molecular Medicine and.
  • Jury A; Medical Research Council Institute of Genetics and Molecular Medicine and.
  • Williams J; Centre for Clinical Brain Sciences, Edinburgh University, Edinburgh, United Kingdom.
  • Scolding N; Institute of Clinical Neurosciences, University of Bristol, Bristol, United Kingdom.
  • Bellamy C; Department of Renal Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Gunther C; Department of Dermatology, University Hospital, Technical University Dresden, Dresden, Germany.
  • Ritchie D; Centre for Clinical Brain Sciences, Edinburgh University, Edinburgh, United Kingdom.
  • Gale DP; Centre for Nephrology, Royal Free Hospital, University College London, London, United Kingdom.
  • Kanwar YS; Feinberg School of Medicine, Northwestern University, Chicago, IL.
  • Challis R; National Renal Complement Therapeutics Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Buist H; Department of Cellular Pathology, Royal Victoria Hospital, Newcastle upon Tyne, United Kingdom.
  • Overell J; Institute of Neurological Sciences, Glasgow University, Glasgow, United Kingdom.
  • Weller B; Centre for Clinical Brain Sciences, Edinburgh University, Edinburgh, United Kingdom.
  • Flossmann O; Royal Berkshire Hospital, Reading, United Kingdom.
  • Blunden M; Barts and the London National Health Service Trust, London, United Kingdom.
  • Meyer EP; Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
  • Krucker T; The Scripps Research Institute, La Jolla, CA.
  • Evans SJ; London School of Hygiene & Tropical Medicine, London, United Kingdom; and.
  • Campbell IL; School of Molecular Bioscience, University of Sydney, Sydney, Australia.
  • Jackson AP; Medical Research Council Institute of Genetics and Molecular Medicine and.
  • Chandran S; Centre for Clinical Brain Sciences, Edinburgh University, Edinburgh, United Kingdom.
  • Hunt DP; Medical Research Council Institute of Genetics and Molecular Medicine and.
Blood ; 128(24): 2824-2833, 2016 12 15.
Article en En | MEDLINE | ID: mdl-27663672
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Microvasos / Microangiopatías Trombóticas Tipo de estudio: Etiology_studies / Prognostic_studies Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Microvasos / Microangiopatías Trombóticas Tipo de estudio: Etiology_studies / Prognostic_studies Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article